HF
CRBU icon

HRT Financial’s Caribou Biosciences CRBU Stock Holding History

HRT Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78,954
Closed -$150K – 4375
2026
Q1 		$150K Buy
+78,954
New +$136K ﹤0.01% 3265
2025
Q3 		– Sell
-105,865
Closed -$133K – 2971
2025
Q2 		$133K Buy
+105,865
New +$104K ﹤0.01% 2152
2024
Q1 		– Sell
-12,912
Closed -$73K – 2433
2023
Q4 		$73K Buy
+12,912
New +$63.8K ﹤0.01% 1924
2023
Q3 		– Sell
-77,467
Closed -$329K – 2491
2023
Q2 		$329K Buy
+77,467
New +$348K ﹤0.01% 1569
2022
Q3 		– Sell
-50,650
Closed -$275K – 2904
2022
Q2 		$275K Buy
+50,650
New +$387K ﹤0.01% 2075

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HRT Financial's CRBU Position: Q2 2026 in Review

HRT Financial sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 78,954 shares — an estimated $150K sold.

HRT Financial first reported a position in CRBU in Q2 2022 and held it in 5 quarters. The position peaked at $329K in Q2 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • HRT Financial reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 78,954 Caribou Biosciences shares in Q2 2026, an estimated $150K.
  • HRT Financial first reported a position in Caribou Biosciences in Q2 2022 and held it in 5 quarters.
  • HRT Financial's Caribou Biosciences position peaked at $329K in Q2 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.